ATR anticorps (C-Term) (FITC)
Aperçu rapide pour ATR anticorps (C-Term) (FITC) (ABIN1969838)
Antigène
Voir toutes ATR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Protein G purified
-
Immunogène
-
KLH conjugated synthetic peptide selected from the C-terminal region of human ATR.
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: ELISA, IHC
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Date de péremption
- 6 months
-
-
- ATR (ATR serine/threonine kinase (ATR))
-
Autre désignation
- ATR
-
Sujet
-
Name/Gene ID: ATR
Subfamily: PI3/PI4
Family: Protein Kinase
Synonyms: ATR, FRAP-related protein-1, FCTCS, SCKL1, MEC1, Protein kinase ATR, Rad3 related protein, SCKL, FRAP-related protein 1, FRP1 -
ID gène
- 545
-
Pathways
- Positive Regulation of Response to DNA Damage Stimulus
Antigène
-